首页 > 最新文献

Revista de la Facultad de Ciencias Medicas de Cordoba最新文献

英文 中文
[Real-life study with pharmaceutical cannabidiol in refractory epilepsy] [药用大麻二酚治疗难治性癫痫的现实研究]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45350
Luis Angel Di Giuseppe, Juan Ignacio Appendino, María Del Carmen García, Karina Elena Alvarez, Gabriela Buela, Mariana Andrea Burgos, María Lourdes Posadas-Martínez, Maria Celeste Puga

Pharmaceutical-grade cannabidiol (CBD) is an alternative treatment for patients with drug-resistant epilepsy (DRE). In 2022, the Italian Hospital of Buenos Aires implemented a non-medical change (NMC) of treatment, replacing one commercial pharmaceutical-grade CBD product with another, the latter also being the initial option for new patients.

Our objective was to evaluate the clinical outcomes of the commercial product change in this population.

Methods: Retrospective cohort of DRE patients who either switched from one commercial pharmaceutical-grade CBD product to another or started treatment with the new product. The clinical response was evaluated by changes in seizure frequency, perception of change with the Patient Global Impression of Change (PGIC) scale, and safety considering discontinuation and/or the presence of adverse effects.

Results: Nineteen patients were included, 12 in the change group and 7 in the new start group (7 pediatric and 12 adults). One patient discontinued treatment due to lack of response. Among those who completed follow-up, 8 (44%) reduced seizure frequency, 6 (33%) showed no change, and 4 (22%) increased seizure frequency. According to the PGIC scale, 9 (50%) remained unchanged, 5 (28%) reported barely noticeable changes, and 4 (22%) reported improvement. Adverse events were mild and transient.

Conclusion: The new commercial pharmaceutical-grade CBD product is a safe and valid option both for substitution and initial treatment in patients with DRE. During the treatment period, patients perceived stability or improvement according to the PGIC scale.

药用级大麻二酚(CBD)是耐药癫痫(DRE)患者的替代治疗方法。2022年,意大利布宜诺斯艾利斯医院实施了一项非医疗改变(NMC)治疗,用另一种商业制药级CBD产品取代了另一种产品,后者也是新患者的首选。我们的目的是评估商业产品变化在这一人群中的临床结果。方法:对从一种商业药物级CBD产品切换到另一种或开始使用新产品治疗的DRE患者进行回顾性队列研究。临床反应通过癫痫发作频率的变化、患者总体变化印象(PGIC)量表的变化感知以及考虑到停药和/或存在不良反应的安全性来评估。结果:纳入19例患者,其中12例为改变组,7例为新开始组(7例儿童,12例成人)。一名患者因缺乏反应而停止治疗。在完成随访的患者中,癫痫发作频率降低8例(44%),无变化6例(33%),癫痫发作频率增加4例(22%)。根据PGIC量表,9个(50%)保持不变,5个(28%)报告几乎没有明显变化,4个(22%)报告改善。不良事件轻微且短暂。结论:新的商业药用级CBD产品是DRE患者替代和初始治疗的安全有效的选择。在治疗期间,根据PGIC量表,患者感觉稳定或改善。
{"title":"[Real-life study with pharmaceutical cannabidiol in refractory epilepsy]","authors":"Luis Angel Di Giuseppe, Juan Ignacio Appendino, María Del Carmen García, Karina Elena Alvarez, Gabriela Buela, Mariana Andrea Burgos, María Lourdes Posadas-Martínez, Maria Celeste Puga","doi":"10.31053/1853.0605.v82.n1.45350","DOIUrl":"10.31053/1853.0605.v82.n1.45350","url":null,"abstract":"<p><p>Pharmaceutical-grade cannabidiol (CBD) is an alternative treatment for patients with drug-resistant epilepsy (DRE). In 2022, the Italian Hospital of Buenos Aires implemented a non-medical change (NMC) of treatment, replacing one commercial pharmaceutical-grade CBD product with another, the latter also being the initial option for new patients.</p><p><p>Our objective was to evaluate the clinical outcomes of the commercial product change in this population.</p><p><strong>Methods: </strong>Retrospective cohort of DRE patients who either switched from one commercial pharmaceutical-grade CBD product to another or started treatment with the new product. The clinical response was evaluated by changes in seizure frequency, perception of change with the Patient Global Impression of Change (PGIC) scale, and safety considering discontinuation and/or the presence of adverse effects.</p><p><strong>Results: </strong>Nineteen patients were included, 12 in the change group and 7 in the new start group (7 pediatric and 12 adults). One patient discontinued treatment due to lack of response. Among those who completed follow-up, 8 (44%) reduced seizure frequency, 6 (33%) showed no change, and 4 (22%) increased seizure frequency. According to the PGIC scale, 9 (50%) remained unchanged, 5 (28%) reported barely noticeable changes, and 4 (22%) reported improvement. Adverse events were mild and transient.</p><p><strong>Conclusion: </strong>The new commercial pharmaceutical-grade CBD product is a safe and valid option both for substitution and initial treatment in patients with DRE. During the treatment period, patients perceived stability or improvement according to the PGIC scale.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"110-126"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Long-term Titanium mesh cage implant failure after total en bloc spondylectomy due to spinal chondrosarcoma: case report and literature review] 脊柱软骨肉瘤全椎体切除术后长期钛网笼植入失败1例报告并文献复习
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44999
María Belén Ginetti, Pablo Oyhamburu, Martín Bosio, Fernando Di Tullio

Objective: To report an unusual titanium mesh cage failure after ten years of follow-up.

Clinical case: A 40-year-old woman diagnosed with low-grade spinal chondrosarcoma underwent a total en-bloc spondylenctomy (TES) surgery. This technique required a wide resection, anterior reconstruction with a titanium mesh cage (TMC), and posterior stabilization. For several years a favorable clinical outcome was achieved. After 10 years of follow-up, the patient developed acute non-traumatic low back pain without neurological repercussions. The images confirmed a rupture of the titanium cage. After ruling out tumor recurrence, the patient went through spinal instrumentation revision.

Conclusion: Isolated TMC rupture is a rare event scarcely reported in the literature. There is a strong recommendation to instrument two levels proximal and distal to the bone defect in 360° reconstructions after a TES. Stability had likely been lost over the years due to the slow resorption of the bone graft. We consider necessary studies with a higher casuistry and level of evidence to analyze the contributing factors for the event of TMC rupture.

目的:报告一例罕见的钛网笼失效病例。临床病例:一名40岁的女性诊断为低级别脊柱软骨肉瘤,接受了全椎体脊柱炎切除术(TES)手术。该技术需要广泛切除,用钛网笼(TMC)进行前路重建,并进行后路稳定。几年来取得了良好的临床结果。经过10年的随访,患者出现急性非创伤性腰痛,无神经反应。图像证实了钛笼子的破裂。排除肿瘤复发后,患者进行脊柱内固定翻修。结论:孤立性TMC破裂是一种罕见的事件,文献报道很少。强烈建议在TES手术后360°重建中对骨缺损近端和远端进行两个水平的测量。由于骨移植物的缓慢吸收,多年来可能失去了稳定性。我们考虑必要的研究与更高的神秘性和证据水平来分析TMC破裂事件的影响因素。
{"title":"[Long-term Titanium mesh cage implant failure after total en bloc spondylectomy due to spinal chondrosarcoma: case report and literature review]","authors":"María Belén Ginetti, Pablo Oyhamburu, Martín Bosio, Fernando Di Tullio","doi":"10.31053/1853.0605.v82.n1.44999","DOIUrl":"10.31053/1853.0605.v82.n1.44999","url":null,"abstract":"<p><strong>Objective: </strong>To report an unusual titanium mesh cage failure after ten years of follow-up.</p><p><strong>Clinical case: </strong>A 40-year-old woman diagnosed with low-grade spinal chondrosarcoma underwent a total en-bloc spondylenctomy (TES) surgery. This technique required a wide resection, anterior reconstruction with a titanium mesh cage (TMC), and posterior stabilization. For several years a favorable clinical outcome was achieved. After 10 years of follow-up, the patient developed acute non-traumatic low back pain without neurological repercussions. The images confirmed a rupture of the titanium cage. After ruling out tumor recurrence, the patient went through spinal instrumentation revision.</p><p><strong>Conclusion: </strong>Isolated TMC rupture is a rare event scarcely reported in the literature. There is a strong recommendation to instrument two levels proximal and distal to the bone defect in 360° reconstructions after a TES. Stability had likely been lost over the years due to the slow resorption of the bone graft. We consider necessary studies with a higher casuistry and level of evidence to analyze the contributing factors for the event of TMC rupture.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"154-164"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The implications of Argentina's withdrawal from the world health organization] [阿根廷退出世界卫生组织的影响]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.48157
Eduardo Cuestas

The implications of Argentina's withdrawal from the world health organization

阿根廷退出世界卫生组织的影响
{"title":"[The implications of Argentina's withdrawal from the world health organization]","authors":"Eduardo Cuestas","doi":"10.31053/1853.0605.v82.n1.48157","DOIUrl":"10.31053/1853.0605.v82.n1.48157","url":null,"abstract":"<p><p>The implications of Argentina's withdrawal from the world health organization</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Liberation of mechanical ventilation in tracheostomized pediatric patients during their stay in the intensive care unit] 【气管造口术患儿重症监护期间机械通气的解放】
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45243
Julia Inés Simonassi, María Tatiana Canzobre, Victoria Eleonora Lopez Fiorito, Cinthia Giselle Perez, Solana Pellegrini

Introduction: Tracheostomy in pediatric intensive care has a prevalence between 5% and 10% of patients on mechanical ventilation.

Objective: The objective of this study was to determine the duration and outcome of the weaning process from mechanical ventilation (MV) and the behavior according to the reason for the tracheostomy.

Methodology: Data from 59 patients under 18 years of age who received MV and underwent tracheostomy between January 2018 and March 2023 at the Juan P. Garrahan National Pediatric Hospital, Argentina, were retrospectively examined. Demographic variables, reasons for admission to the unit, days on MV, tracheostomy characteristics, and the weaning process from MV were recorded.

Results: The main reasons for tracheostomy were airway disorders (50.8%) and prolonged MV (30.5%). Notable variability was observed in the duration and success of the weaning process among different groups of patients. Patients with airway disorders showed a faster weaning (median: 1.5 days) and higher success in this process, while those with prolonged MV and neurological disorders experienced longer processes (medians: 25.5 and 28 days, respectively) and more patients required partial or total mechanical ventilation at the end of this process. The presence of diaphragmatic dysfunction was more common in those who took longer to wean.

Conclusion: The weaning from MV is a complex process, and the reason for the tracheostomy influences its progression.

导读:气管切开术在儿童重症监护中有5% - 10%的患者使用机械通气。目的:本研究的目的是根据气管切开术的原因确定机械通气(MV)脱机过程的持续时间和结果以及行为。方法:回顾性分析2018年1月至2023年3月在阿根廷Juan P. Garrahan国立儿科医院接受MV并行气管切开术的59例18岁以下患者的数据。记录人口统计变量、入院原因、MV天数、气管造口术特征和MV脱机过程。结果:气管切开术的主要原因是气道障碍(50.8%)和MV延长(30.5%)。在不同组的患者中,在持续时间和成功的断奶过程中观察到显著的差异。气道障碍患者在该过程中脱机速度更快(中位数:1.5天),成功率更高,而MV延长和神经障碍患者脱机时间更长(中位数:25.5天和28天),并且在该过程结束时需要部分或全部机械通气的患者更多。膈肌功能障碍的出现在断奶时间较长的人群中更为常见。结论:气管切开是一个复杂的过程,气管切开的原因影响其进展。
{"title":"[Liberation of mechanical ventilation in tracheostomized pediatric patients during their stay in the intensive care unit]","authors":"Julia Inés Simonassi, María Tatiana Canzobre, Victoria Eleonora Lopez Fiorito, Cinthia Giselle Perez, Solana Pellegrini","doi":"10.31053/1853.0605.v82.n1.45243","DOIUrl":"10.31053/1853.0605.v82.n1.45243","url":null,"abstract":"<p><strong>Introduction: </strong>Tracheostomy in pediatric intensive care has a prevalence between 5% and 10% of patients on mechanical ventilation.</p><p><strong>Objective: </strong>The objective of this study was to determine the duration and outcome of the weaning process from mechanical ventilation (MV) and the behavior according to the reason for the tracheostomy.</p><p><strong>Methodology: </strong>Data from 59 patients under 18 years of age who received MV and underwent tracheostomy between January 2018 and March 2023 at the Juan P. Garrahan National Pediatric Hospital, Argentina, were retrospectively examined. Demographic variables, reasons for admission to the unit, days on MV, tracheostomy characteristics, and the weaning process from MV were recorded.</p><p><strong>Results: </strong>The main reasons for tracheostomy were airway disorders (50.8%) and prolonged MV (30.5%). Notable variability was observed in the duration and success of the weaning process among different groups of patients. Patients with airway disorders showed a faster weaning (median: 1.5 days) and higher success in this process, while those with prolonged MV and neurological disorders experienced longer processes (medians: 25.5 and 28 days, respectively) and more patients required partial or total mechanical ventilation at the end of this process. The presence of diaphragmatic dysfunction was more common in those who took longer to wean.</p><p><strong>Conclusion: </strong>The weaning from MV is a complex process, and the reason for the tracheostomy influences its progression.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"78-94"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Titanium mesh cage implant failure after total en bloc spondylectomy due to spinal chondrosarcoma 脊柱软骨肉瘤全椎体切除术后长期钛网笼植入失败
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44961
Ezequiel Martinez, Matias Pereira Duarte, Gonzalo Kido, Gaston Camino-Willhuber, Julio Bassani, Marcelo Gruenberg, Matias Petracchi

Objective: To report an unusual titanium mesh cage failure after ten years of follow-up.

Clinical case: A 40-year-old woman diagnosed with low-grade spinal chondrosarcoma underwent a total en-bloc spondylenctomy (TES) surgery. This technique required a wide resection, anterior reconstruction with a titanium mesh cage (TMC), and posterior stabilization. For several years a favorable clinical outcome was achieved. After 10 years of follow-up, the patient developed acute non-traumatic low back pain without neurological repercussions. The images confirmed a rupture of the titanium cage. After ruling out tumor recurrence, the patient went through spinal instrumentation revision.

Conclusion: Isolated TMC rupture is a rare event scarcely reported in the literature. There is a strong recommendation to instrument two levels proximal and distal to the bone defect in 360° reconstructions after a TES. Stability had likely been lost over the years due to the slow resorption of the bone graft. We consider necessary studies with a higher casuistry and level of evidence to analyze the contributing factors for the event of TMC rupture.

目的:报告一例罕见的钛网笼失效病例。临床病例:一名40岁的女性诊断为低级别脊柱软骨肉瘤,接受了全椎体脊柱炎切除术(TES)手术。该技术需要广泛切除,用钛网笼(TMC)进行前路重建,并进行后路稳定。几年来取得了良好的临床结果。经过10年的随访,患者出现急性非创伤性腰痛,无神经反应。图像证实了钛笼子的破裂。排除肿瘤复发后,患者进行脊柱内固定翻修。结论:孤立性TMC破裂是一种罕见的事件,文献报道很少。强烈建议在TES手术后360°重建中对骨缺损近端和远端进行两个水平的测量。由于骨移植物的缓慢吸收,多年来可能失去了稳定性。我们考虑必要的研究与更高的神秘性和证据水平来分析TMC破裂事件的影响因素。
{"title":"Long-term Titanium mesh cage implant failure after total en bloc spondylectomy due to spinal chondrosarcoma","authors":"Ezequiel Martinez, Matias Pereira Duarte, Gonzalo Kido, Gaston Camino-Willhuber, Julio Bassani, Marcelo Gruenberg, Matias Petracchi","doi":"10.31053/1853.0605.v82.n1.44961","DOIUrl":"10.31053/1853.0605.v82.n1.44961","url":null,"abstract":"<p><strong>Objective: </strong>To report an unusual titanium mesh cage failure after ten years of follow-up.</p><p><strong>Clinical case: </strong>A 40-year-old woman diagnosed with low-grade spinal chondrosarcoma underwent a total en-bloc spondylenctomy (TES) surgery. This technique required a wide resection, anterior reconstruction with a titanium mesh cage (TMC), and posterior stabilization. For several years a favorable clinical outcome was achieved. After 10 years of follow-up, the patient developed acute non-traumatic low back pain without neurological repercussions. The images confirmed a rupture of the titanium cage. After ruling out tumor recurrence, the patient went through spinal instrumentation revision.</p><p><strong>Conclusion: </strong>Isolated TMC rupture is a rare event scarcely reported in the literature. There is a strong recommendation to instrument two levels proximal and distal to the bone defect in 360° reconstructions after a TES. Stability had likely been lost over the years due to the slow resorption of the bone graft. We consider necessary studies with a higher casuistry and level of evidence to analyze the contributing factors for the event of TMC rupture.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"140-153"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications] 单克隆抗体在过敏症中的应用:发展、药理学和临床应用。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.31053/1853.0605.v81.n4.44413
Selene Pury, Ricardo José Saranz, María José Irastorza, Laura Veronica Sasia, Pilar Visconti, Graciela Alegre, Natalia Andrea Lozano, Yanina Viviana Berardi, Alejandro Lozano

The understanding of immunological processes associated with allergic diseases and advancements in antibody bioengineering has driven the development of specific biological therapies. Monoclonal antibodies, selectively targeting cytokines involved in the pathogenesis of allergic processes or their receptors, have emerged as a promising tool in treating various conditions, including asthma, allergic rhinitis, urticaria, and severe atopic dermatitis. Since the approval of the first anti-CD3 mouse monoclonal antibody in 1986, remarkable progress has been achieved, marked by the development of chimeric, 'humanized,' and 'fully human' antibodies. The 'humanization' of monoclonal antibodies has played a crucial role in reducing the risk of immunogenicity and minimizing adverse effects, thereby notably enhancing the safety and efficacy of these therapeutic interventions.The aim of this article is to address the characterization, development, pharmacokinetics, pharmacodynamics, and clinical utility of monoclonal antibodies, with a primary focus on allergic diseases.

对与过敏性疾病相关的免疫过程和抗体生物工程的理解的进步导致了特定生物疗法的发展。单克隆抗体选择性地靶向参与过敏过程发病机制的细胞因子或其受体,已成为治疗各种疾病的一种有前途的工具,如哮喘、过敏性鼻炎、荨麻疹和严重的特应性皮炎。起源自通过第一个反物质monoclonal anti-CD3 murino在1986年,已出现一段漫长的征程,为特点的空想,因分子结构的抗体免疫球蛋白是类似于人类humanizados”和人类到底所谓“完全相同”。单克隆抗体的“人性化”大大降低了免疫原性的风险和不良反应的发生率,显著提高了这些疗法的安全性和有效性。本文旨在探讨单克隆抗体的表征、发展、药代动力学、药代动力学和临床效用,主要集中在过敏性疾病中。
{"title":"[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]","authors":"Selene Pury, Ricardo José Saranz, María José Irastorza, Laura Veronica Sasia, Pilar Visconti, Graciela Alegre, Natalia Andrea Lozano, Yanina Viviana Berardi, Alejandro Lozano","doi":"10.31053/1853.0605.v81.n4.44413","DOIUrl":"10.31053/1853.0605.v81.n4.44413","url":null,"abstract":"<p><p>The understanding of immunological processes associated with allergic diseases and advancements in antibody bioengineering has driven the development of specific biological therapies. Monoclonal antibodies, selectively targeting cytokines involved in the pathogenesis of allergic processes or their receptors, have emerged as a promising tool in treating various conditions, including asthma, allergic rhinitis, urticaria, and severe atopic dermatitis. Since the approval of the first anti-CD3 mouse monoclonal antibody in 1986, remarkable progress has been achieved, marked by the development of chimeric, 'humanized,' and 'fully human' antibodies. The 'humanization' of monoclonal antibodies has played a crucial role in reducing the risk of immunogenicity and minimizing adverse effects, thereby notably enhancing the safety and efficacy of these therapeutic interventions.\u0000\u0000The aim of this article is to address the characterization, development, pharmacokinetics, pharmacodynamics, and clinical utility of monoclonal antibodies, with a primary focus on allergic diseases.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 4","pages":"804-823"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain metastases in a patient with antecedent of cardiac myxoma: a case report and review of literature 有心脏混血儿病史的患者的脑转移
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.31053/1853.0605.v81.n4.44662
Raymundo Solís-Gómez, Natalia Dávalos Cabral, Gerardo Arrieta Limón, Brandon Alberto Hurtado Presa, Andrea Salgado Alvear, Laura Michelle Reyes Martínez, Fabiola Eunice Serrano Arias

Introduction: Cardiac myxomas are the most common benign neoplasms of the heart, mainly located in the left atrium. The preferred treatment is the resection of the myxoma. This method not only prevents complications but also has a low recurrence rate. Brain metastases usually occur when tumor fragments embolize and implant at the destination place.

Case presentation: We report the case of a patient with multiple brain metastases, found during follow-up, after the presentation of stroke. This case stands out because the embolization causing the brain metastasis might have occurred either during the ischemic stroke or when the cardiac myxoma was being removed. In our case, the patient was evaluated during follow-up with brain magnetic resonance imaging, finding multiple metastatic lesions. To determine the type of lesion, a biopsy was performed and the histological diagnosis, which was indicative of metastatic tissue of left atrial myxoma.

Conclusion: Patients with cardioembolism should undergo a complete diagnostic protocol to distinguish the cause of embolization, whether it is a blood clot or a tumor embolus. The treatment of choice is the resection of the myxoma, which cures the primary neurological symptoms and prevents neurological complications. However, it is essential to maintain active surveillance for a longer time for the detection and appropriate treatment of brain metastases.

介绍。心脏混合瘤是最常见的良性心脏肿瘤,主要位于左心房。首选的治疗方法是切除粘液瘤。这种方法不仅可以防止并发症,而且复发率也很低。脑转移通常发生在肿瘤碎片栓塞并植入目标部位时。介绍的情况下。我们报道了一个病例,一个患有多发性脑转移的病人,在报告中风后的随访中发现。这个病例是值得注意的,因为导致脑转移的栓塞可能发生在缺血性中风和心脏肌瘤切除期间。在我们的案例中,患者在脑核磁共振随访期间进行了评估,发现了多个转移性病变。为了确定病变的类型,进行了活检和组织学诊断的指示性转移组织左心房粘液瘤。结论。心脏栓塞症患者应遵循一套完整的诊断方案,以区分栓塞的原因,无论是血栓还是肿瘤栓塞。选择的治疗方法是切除粘液瘤,它可以治愈主要的神经症状,防止神经并发症。然而,更长期的积极监测对于发现和适当治疗脑转移至关重要。
{"title":"Brain metastases in a patient with antecedent of cardiac myxoma: a case report and review of literature","authors":"Raymundo Solís-Gómez, Natalia Dávalos Cabral, Gerardo Arrieta Limón, Brandon Alberto Hurtado Presa, Andrea Salgado Alvear, Laura Michelle Reyes Martínez, Fabiola Eunice Serrano Arias","doi":"10.31053/1853.0605.v81.n4.44662","DOIUrl":"10.31053/1853.0605.v81.n4.44662","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiac myxomas are the most common benign neoplasms of the heart, mainly located in the left atrium. The preferred treatment is the resection of the myxoma. This method not only prevents complications but also has a low recurrence rate. Brain metastases usually occur when tumor fragments embolize and implant at the destination place.</p><p><strong>Case presentation: </strong>We report the case of a patient with multiple brain metastases, found during follow-up, after the presentation of stroke. This case stands out because the embolization causing the brain metastasis might have occurred either during the ischemic stroke or when the cardiac myxoma was being removed. In our case, the patient was evaluated during follow-up with brain magnetic resonance imaging, finding multiple metastatic lesions. To determine the type of lesion, a biopsy was performed and the histological diagnosis, which was indicative of metastatic tissue of left atrial myxoma.</p><p><strong>Conclusion: </strong>Patients with cardioembolism should undergo a complete diagnostic protocol to distinguish the cause of embolization, whether it is a blood clot or a tumor embolus. The treatment of choice is the resection of the myxoma, which cures the primary neurological symptoms and prevents neurological complications. However, it is essential to maintain active surveillance for a longer time for the detection and appropriate treatment of brain metastases.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 4","pages":"783-792"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic Hepaticojejunostomy. Initial experience in 21 consecutive cases. 腹腔镜Hepaticojejunostomy。连续21例的初步经验。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.31053/1853.0605.v81.n4.44694
Christian Janikow, Maisa AlIkhwan, Mohammed Nasser, Ahmed Bayazeed, Esraa Alshahrani

Introduction: laparoscopic hepaticojejunostomy is a complex procedure indicated for different pathologies. Still, the laparoscopic approach is not the gold standard, but it is well known for its benefits regarding post operative recovery. We present our experience in 21 consecutive cases of laparoscopic hepaticojejunostomy done at King Fahad General Hospital in Jeddah.

Methods: 21 consecutives laparoscopic hepaticojejunostomies were done from January 2022 to December 2023. Gender: 10 male and 11 female, average age 46 years. The most common indication is due to multiple common bile duct stones.

Results: average surgical time: 180 minutes, average blood loss: 168 ml. According to Clavien-Dindo´s classification, we recorded one complication type: 3A. Average discharge days were 5.5; no mortality was reported.

Conclusion: We believe that the success of laparoscopic hepaticojejunostomy is related to excellent knowledge of the biliary system and an experienced surgeon in advanced laparoscopic procedures.

简介:腹腔镜肝空肠吻合术是一项复杂的手术,适用于不同的病理。尽管如此,腹腔镜方法并不是金标准,但它对术后恢复的好处是众所周知的。我们介绍了我们在吉达法赫德国王总医院连续21例腹腔镜肝空肠吻合术的经验。方法:于2022年1月至2023年12月连续行21例腹腔镜肝空肠吻合术。性别:男性10人,女性11人,平均年龄46岁。最常见的适应症是由于多发胆总管结石。结果:平均手术时间:180分钟,平均出血量:168 ml。根据Clavien-Dindo分类,我们记录到1个并发症类型:3A。平均出院天数5.5天;没有死亡报告。结论:我们认为腹腔镜肝空肠吻合术的成功与对胆道系统的了解和经验丰富的外科医生的先进腹腔镜手术有关。
{"title":"Laparoscopic Hepaticojejunostomy. Initial experience in 21 consecutive cases.","authors":"Christian Janikow, Maisa AlIkhwan, Mohammed Nasser, Ahmed Bayazeed, Esraa Alshahrani","doi":"10.31053/1853.0605.v81.n4.44694","DOIUrl":"10.31053/1853.0605.v81.n4.44694","url":null,"abstract":"<p><strong>Introduction: </strong>laparoscopic hepaticojejunostomy is a complex procedure indicated for different pathologies. Still, the laparoscopic approach is not the gold standard, but it is well known for its benefits regarding post operative recovery. We present our experience in 21 consecutive cases of laparoscopic hepaticojejunostomy done at King Fahad General Hospital in Jeddah.</p><p><strong>Methods: </strong>21 consecutives laparoscopic hepaticojejunostomies were done from January 2022 to December 2023. Gender: 10 male and 11 female, average age 46 years. The most common indication is due to multiple common bile duct stones.</p><p><strong>Results: </strong>average surgical time: 180 minutes, average blood loss: 168 ml. According to Clavien-Dindo´s classification, we recorded one complication type: 3A. Average discharge days were 5.5; no mortality was reported.</p><p><strong>Conclusion: </strong>We believe that the success of laparoscopic hepaticojejunostomy is related to excellent knowledge of the biliary system and an experienced surgeon in advanced laparoscopic procedures.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 4","pages":"793-803"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of symptomatic endobronchial hamartoma by bronchoscopy. 支气管镜治疗症状性支气管内错构瘤。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.31053/1853.0605.v81.n4.44412
María Emilia Cano, Felipe Pagnoncelli Fachin, José Carlos Felicetti

Hamartomas are benign tumors characterized by disorganized tissue native to a specific anatomical location. We present the case of a 61-year-old male with a history of COVID-19 infection who presented with a persistent cough. Chest tomography revealed an endobronchial lesion, which led to further investigation with a bronchoscopy. Using a cold loop, the lesion was successfully resected and pathology confirmed the diagnosis of a hamartoma.  Endobronchial resection is the preferred strategy for diagnosing and treating these tumors. This case highlights the successful management of an endobronchial hamartoma in a patient with a history of COVID-19 infection, emphasizing the importance of thorough investigation and appropriate intervention in similar cases.

Hamartomas 是一种良性肿瘤,其特点是特定解剖位置的组织紊乱。本病例是一名 61 岁的男性,有 COVID-19 感染史,并伴有持续咳嗽。胸部断层扫描发现支气管内病变,因此进一步进行了支气管镜检查。使用冷环成功切除了病灶,病理确诊为火腿肠瘤。 支气管内切除术是诊断和治疗此类肿瘤的首选策略。本病例强调了对一名有 COVID-19 感染史的患者支气管内火腿肠瘤的成功治疗,强调了对类似病例进行彻底检查和适当干预的重要性。
{"title":"Treatment of symptomatic endobronchial hamartoma by bronchoscopy.","authors":"María Emilia Cano, Felipe Pagnoncelli Fachin, José Carlos Felicetti","doi":"10.31053/1853.0605.v81.n4.44412","DOIUrl":"10.31053/1853.0605.v81.n4.44412","url":null,"abstract":"<p><p>Hamartomas are benign tumors characterized by disorganized tissue native to a specific anatomical location. We present the case of a 61-year-old male with a history of COVID-19 infection who presented with a persistent cough. Chest tomography revealed an endobronchial lesion, which led to further investigation with a bronchoscopy. Using a cold loop, the lesion was successfully resected and pathology confirmed the diagnosis of a hamartoma.  Endobronchial resection is the preferred strategy for diagnosing and treating these tumors. This case highlights the successful management of an endobronchial hamartoma in a patient with a history of COVID-19 infection, emphasizing the importance of thorough investigation and appropriate intervention in similar cases.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 4","pages":"861-868"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Unveiling Hormonal Secrets] 揭开荷尔蒙的秘密。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.31053/1853.0605.v81.n4.44304
Andrés Felipe García Ramos, Claudia Monsalve Arango, Jose Fernando Botero Arango, Natalia Aristizabal Henao, Nathalia Buitrago Gómez, William Fernando Cabarcas Lopez

Background: Thyroid dysfunction during pregnancy negatively impacts both the woman and her offspring, with the early gestational period being critical for potential repercussions. Establishing pre-conception and during-conception care strategies is crucial for favorable pregnancy outcomes.

Objective: This review aims to compile the most recent scientific evidence to guide diagnostic and therapeutic approaches based on clinical cases, including a description of thyroid physiology during pregnancy and strategies for identifying high-risk patients for treatment.

Method: This bibliographic review combined DeCS and MeSH terms from the PICOT question, spanning the period from 2015 to 2022 across 5 databases. Articles in both English and Spanish were included if they addressed the PICOT question and contributed to the explanation of two case reports.

Results: A total of 1452 articles were collected, which, following an initial elimination of duplicates and subsequent blind review based on inclusion and exclusion criteria by two reviewers, resulted in 32 articles included in this review.

Conclusions: Overt hypothyroidism is associated with adverse maternal-fetal outcomes, and its treatment improves these complications. However, in borderline conditions such as subclinical hypothyroidism, isolated hypothyroxinemia, and thyroid autoimmune conditions, uncertainty about the treatment's impact persists due to a scarcity of controlled trials. Emphasizing the importance of all physicians being familiar with this condition during gestation.

背景:妊娠期间甲状腺功能障碍对妇女及其后代有负面影响,妊娠早期是可能影响的关键时期。制定怀孕前和怀孕期间的护理战略对良好的妊娠结果至关重要。目的:本综述旨在收集最新的科学证据,以指导以临床病例为基础的诊断和治疗方法,包括对妊娠期甲状腺生理学的描述和识别治疗高危患者的策略。方法:本文献综述结合了PICOT问题的DeCs和MeSH术语,涵盖了2015年至2022年期间的5个数据库。包括英文和西班牙文的文章,回答了PICOT的问题,并有助于解释两份案例报告。结果:共收集了1452篇文章,其中32篇文章被纳入本综述,在第一次重复删除后,由2名盲评审人员进行了纳入/排除过滤。结论:甲状腺功能减慢与母婴阴性结果有关,治疗可改善这些并发症。然而,在亚临床甲状腺功能减退症、孤立性甲状腺功能减退症和甲状腺自身免疫等边缘状态下,由于缺乏对照试验,治疗效果的不确定性仍然存在。它强调了所有医生在怀孕期间了解这种情况的重要性。
{"title":"[Unveiling Hormonal Secrets]","authors":"Andrés Felipe García Ramos, Claudia Monsalve Arango, Jose Fernando Botero Arango, Natalia Aristizabal Henao, Nathalia Buitrago Gómez, William Fernando Cabarcas Lopez","doi":"10.31053/1853.0605.v81.n4.44304","DOIUrl":"10.31053/1853.0605.v81.n4.44304","url":null,"abstract":"<p><strong>Background: </strong>Thyroid dysfunction during pregnancy negatively impacts both the woman and her offspring, with the early gestational period being critical for potential repercussions. Establishing pre-conception and during-conception care strategies is crucial for favorable pregnancy outcomes.</p><p><strong>Objective: </strong>This review aims to compile the most recent scientific evidence to guide diagnostic and therapeutic approaches based on clinical cases, including a description of thyroid physiology during pregnancy and strategies for identifying high-risk patients for treatment.</p><p><strong>Method: </strong>This bibliographic review combined DeCS and MeSH terms from the PICOT question, spanning the period from 2015 to 2022 across 5 databases. Articles in both English and Spanish were included if they addressed the PICOT question and contributed to the explanation of two case reports.</p><p><strong>Results: </strong>A total of 1452 articles were collected, which, following an initial elimination of duplicates and subsequent blind review based on inclusion and exclusion criteria by two reviewers, resulted in 32 articles included in this review.</p><p><strong>Conclusions: </strong>Overt hypothyroidism is associated with adverse maternal-fetal outcomes, and its treatment improves these complications. However, in borderline conditions such as subclinical hypothyroidism, isolated hypothyroxinemia, and thyroid autoimmune conditions, uncertainty about the treatment's impact persists due to a scarcity of controlled trials. Emphasizing the importance of all physicians being familiar with this condition during gestation.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"81 4","pages":"824-841"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de la Facultad de Ciencias Medicas de Cordoba
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1